Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Association between NAT2 polymorphisms and acute leukemia risk: A meta-analysis.

Zhu X, Liu Y, Chen G, Guo Q, Zhang Z, Zhao L, Wei R, Yin X, Zhang Y, Wang B, Li X.

Medicine (Baltimore). 2019 Mar;98(12):e14942. doi: 10.1097/MD.0000000000014942.

2.

N-acetyltransferase 2 phenotype and risk of esophageal cancer: a meta analysis.

Ma RL, Min L, Chen D, Tao WP, Ge W, Wu YG.

Cancer Biomark. 2013 Jan 1;13(6):447-55. doi: 10.3233/CBM-130387.

PMID:
24595082
3.

N-acetyltransferase 2 gene polymorphisms are associated with susceptibility to cancer: a meta-analysis.

Tian FS, Shen L, Ren YW, Zhang Y, Yin ZH, Zhou BS.

Asian Pac J Cancer Prev. 2014;15(14):5621-6.

4.

Association Between NAT2 Polymorphisms and Lung Cancer Susceptibility.

Liu C, Cui W, Cong L, Wang L, Ruan X, Jia J, Liu Y, Jia X, Zhang X.

Medicine (Baltimore). 2015 Dec;94(49):e1947. doi: 10.1097/MD.0000000000001947.

5.

Genetic polymorphisms of NAT2 and risk of acute myeloid leukemia: A case-control study.

Zou Y, Dong S, Xu S, Gong Q, Chen J.

Medicine (Baltimore). 2017 Oct;96(42):e7499. doi: 10.1097/MD.0000000000007499.

6.

Genetic variability in N-acetyltransferase 2 gene determines susceptibility to childhood lymphoid or myeloid leukemia in Brazil.

Zanrosso CW, Emerenciano M, Faro A, Gonçalves BA, Mansur MB, Pombo-de-Oliveira MS.

Leuk Lymphoma. 2012 Feb;53(2):323-7. doi: 10.3109/10428194.2011.619605. Epub 2011 Nov 25.

PMID:
21888617
7.
8.

N-Acetyltransferase 2 (NAT2) polymorphism as a risk modifier of susceptibility to pediatric acute lymphoblastic leukemia.

Kamel AM, Ebid GT, Moussa HS.

Tumour Biol. 2015 Aug;36(8):6341-8. doi: 10.1007/s13277-015-3320-7. Epub 2015 Mar 25.

PMID:
25804798
9.

Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.

Gu J, Liang D, Wang Y, Lu C, Wu X.

Mutat Res. 2005 Mar 7;581(1-2):97-104. Epub 2004 Dec 16.

PMID:
15725609
10.

NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.

Zhang J, Qiu LX, Wang ZH, Wang JL, He SS, Hu XC.

Breast Cancer Res Treat. 2010 Oct;123(3):877-83. doi: 10.1007/s10549-010-0807-1. Epub 2010 Feb 24.

PMID:
20180012
11.

Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders.

Hirvonen A, Saarikoski ST, Linnainmaa K, Koskinen K, Husgafvel-Pursiainen K, Mattson K, Vainio H.

J Natl Cancer Inst. 1996 Dec 18;88(24):1853-6.

PMID:
8961976
12.

Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group.

Xu WJ, Wen LP, Jiang XX, Ye LY, Meng FH, Guan S, Qian YJ, Wei JF.

Clin Lab. 2017 Feb 1;63(2):287-293. doi: 10.7754/Clin.Lab.2016.160803. Review.

PMID:
28182356
13.

N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients.

Borlak J, Reamon-Buettner SM.

BMC Med Genet. 2006 Jul 9;7:58.

14.

N-acetyltransferase 2 genotype modification of active cigarette smoking on breast cancer risk among hispanic and non-hispanic white women.

Baumgartner KB, Schlierf TJ, Yang D, Doll MA, Hein DW.

Toxicol Sci. 2009 Nov;112(1):211-20. doi: 10.1093/toxsci/kfp199. Epub 2009 Aug 19.

15.

Single nucleotide polymorphism coverage and inference of N-acetyltransferase-2 acetylator phenotypes in wordwide population groups.

Suarez-Kurtz G, Fuchshuber-Moraes M, Struchiner CJ, Parra EJ.

Pharmacogenet Genomics. 2016 Aug;26(8):363-9. doi: 10.1097/FPC.0000000000000225.

PMID:
27136043
16.

Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.

Hein DW, Doll MA.

Pharmacogenomics. 2012 Jan;13(1):31-41. doi: 10.2217/pgs.11.122. Epub 2011 Nov 17.

17.

N-acetyltransferase 2 polymorphism and breast cancer risk with smoking: a case control study in Japanese women.

Hara A, Taira N, Mizoo T, Nishiyama K, Nogami T, Iwamoto T, Motoki T, Shien T, Matsuoka J, Doihara H, Ishihara S, Kawai H, Kawasaki K, Ishibe Y, Ogasawara Y, Miyoshi S.

Breast Cancer. 2017 Mar;24(2):254-262. doi: 10.1007/s12282-016-0696-1. Epub 2016 Apr 11.

PMID:
27068825
18.

Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.

Wu H, Wang X, Zhang L, Mo N, Lv Z.

Clin Genitourin Cancer. 2016 Apr;14(2):122-9. doi: 10.1016/j.clgc.2015.10.007. Epub 2015 Oct 26. Review.

PMID:
26585839
19.

The GSTP1 A1578G polymorphism and the risk of childhood acute lymphoblastic leukemia: results from an updated meta-analysis.

Huang GZ, Shan W, Zeng L, Huang LG.

Genet Mol Res. 2013 Jul 24;12(3):2481-91. doi: 10.4238/2013.July.24.3.

20.

Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations.

Xie HG, Xu ZH, Ou-Yang DS, Shu Y, Yang DL, Wang JS, Yan XD, Huang SL, Wang W, Zhou HH.

Pharmacogenetics. 1997 Dec;7(6):503-14.

PMID:
9429236

Supplemental Content

Support Center